Sunday June 11th-Tuesday June 13th, 2017 The Summit will be held at the Life Sciences Institute, University of British Columbia, Vancouver, BC
The Personalized Medicine Initiative and partners are pleased to announce the 2nd Personalized Medicine Summit 2017, scheduled for June 11-13, 2017 at the University of British Columbia (UBC). This meeting follows on from the highly successful 1st Personalized Summit 2015 at UBC, which resulted in a consensus advisory document, the “Roadmap for Bringing Personalized Medicine to British Columbians”. The Summit will produce an updated Roadmap to assist government, the public and healthcare providers to implement personalized precision medicine to result in more efficient and effective healthcare.
The 2nd Summit will attract an internationally renowned faculty and will be of interest to clinicians, patient advocates, health care providers, academics and representatives from government and industry who are interested in the revolution in healthcare that is being enabled by personalized, molecularly-based medicine. We anticipate approximately 450 attendees.
The deliverable of the summit meeting will be an updated edition of our 2015 publication “Roadmap for Bringing Personalized Medicine to British Columbians” (see attached). This publication summarized the consensus arising from the Personalized Medicine Summit 2015 and made four major recommendations:
- The BC government (Ministries of Health, Finance, Innovation and Advanced Education) should make a commitment to implement personalized medicine.
- BC should establish a coalition of stakeholders to coordinate the whole system change required to implement personalized medicine.
- BC should capitalize on near-term opportunities to integrate molecular medicine technologies into healthcare.
- BC should establish a longitudinal database containing molecular-level “Omic” data for 5,000 British Columbians (over 3 years) in high-cost, high prevalence disease states to drive disease stratification, patient-centric healthcare, translational research and innovation.